At the IGTP TODAY
Researchers from five Catalan research centres have collaborated on a large-scale genetic study, identifying genetic loci and therapeutic targets that could reduce cardiovascular risk by modulating blood metabolites.
Several researchers from IGTP took part in this year's European Researchers' Night in Barcelona. They shared their passion for science through talks and led participants of a workshop via a board game into the midst of a tuberculosis epidemic.
As a strategic initiative under IGTP, GCAT (Genomes for Life) continues to make substantial contributions to public health knowledge. The latest GCAT study, conducted through the COVICAT initiative, signed by Ximena Goldberg and Rafael de Cid, sheds light on the complex interplay between genetic predispositions and environmental stressors in determining depression risk, especially during the COVID-19 lockdown. Published in Scientific Reports.
The collaborative action DATOS-CAT aims to enhance the visibility and scientific impact of population-based cohorts created in Catalonia. Additionally, it seeks to enrich the procedures used in these cohorts, promoting their applicability in other similar contexts. To achieve this, it focuses on improving data interoperability, thereby facilitating their exploitation and use in scientific research.
On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a significant advance in the understanding of how the immune system can prevent the appearance of tumours.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
In 2023, the IGTP has continued to make significant strides in its mission. Here, we review the year's top news stories, reflecting the persistent drive and collaborative spirit that underpin this institution.
The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.
The third General Assembly of the END-VOC Consortium took place on 7 and 8 June hosted by the Barcelona Institute for Global Health (ISGlobal). Germans Trias i Pujol Research Institute (IGTP), who is leading the GCAT project and collaborating in several of the project's work packages, was one of the partners who participated in this meeting attended by more than 50 consortium members.
